Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Zeh

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Gene Therapy|February 3, 2007
A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virusS Yang, Z S Guo, M E O'Malley, et al.
Blood|July 15, 1992
Modulation of myeloid proliferation and differentiation by monoclonal antibodies directed against a protein that interacts with the interleukin-3 receptorD J Tweardy, P A Morel, P L Mott, et al.
Cell Death & Disease|December 17, 2013
Strange attractors: DAMPs and autophagy link tumor cell death and immunityW Hou, Q Zhang, Z Yan, et al.
Human Immunology|February 1, 1994
Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2H J Zeh, G H Leder, M T Lotze, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1992
Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanomaM T Lotze, H J Zeh, E M Elder, et al.
Cell Death and Differentiation|October 17, 2009
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survivalR Kang, D Tang, N E Schapiro, et al.
Cell Death & Disease|October 24, 2014
RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancerR Kang, W Hou, Q Zhang, et al.
Cell Death and Differentiation|July 27, 2025
Correction to: The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survivalR Kang, D Tang, N E Schapiro, et al.
Cancer Research|January 1, 1994
Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivoH Tahara, H J Zeh, W J Storkus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1995
Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vectorH Tahara, L Zitvogel, W J Storkus, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Gene Therapy|February 3, 2007
A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virusS Yang, Z S Guo, M E O'Malley, et al.
Blood|July 15, 1992
Modulation of myeloid proliferation and differentiation by monoclonal antibodies directed against a protein that interacts with the interleukin-3 receptorD J Tweardy, P A Morel, P L Mott, et al.
Cell Death & Disease|December 17, 2013
Strange attractors: DAMPs and autophagy link tumor cell death and immunityW Hou, Q Zhang, Z Yan, et al.
Human Immunology|February 1, 1994
Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2H J Zeh, G H Leder, M T Lotze, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1992
Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanomaM T Lotze, H J Zeh, E M Elder, et al.
Cell Death and Differentiation|October 17, 2009
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survivalR Kang, D Tang, N E Schapiro, et al.
Cell Death & Disease|October 24, 2014
RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancerR Kang, W Hou, Q Zhang, et al.
Cell Death and Differentiation|July 27, 2025
Correction to: The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survivalR Kang, D Tang, N E Schapiro, et al.
Cancer Research|January 1, 1994
Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivoH Tahara, H J Zeh, W J Storkus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1995
Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vectorH Tahara, L Zitvogel, W J Storkus, et al.
Pageof 3